Try our Advanced Search for more refined results
Compliance
-
January 20, 2026
Law360 Names Firms Of The Year
Eight law firms have earned spots as Law360's Firms of the Year, with 48 Practice Group of the Year awards among them, achieving milestones such as high-profile litigation wins at the U.S. Supreme Court and 11-figure merger deals.
-
January 20, 2026
Microsoft Warns Google Play Store Deal Invites Antitrust Harm
Microsoft Corp. urged a California federal judge to reject the proposed Android app distribution settlement in Epic Games' antitrust suit against Google, arguing that the deal would essentially erase the court's injunction requiring Google to open up its Play Store to Microsoft and other competitors.
-
January 20, 2026
Texas AG Says State Diversity Initiatives Breach Constitution
Texas Attorney General Ken Paxton took aim at a plethora of state diversity initiatives in a Monday opinion, declaring that several minority-owned business assistance programs and private hiring practices run afoul of the Texas Constitution.
-
January 20, 2026
Boston Consulting Loses UK Tax Fight Over Partner Pay
Payments to partners made by the U.K. arm of Boston Consulting Group are taxable under rules aimed at preventing avoidance since profit shares were routed through a corporate group and carelessness by the firm caused a loss of tax, a London court ruled Tuesday.
-
January 20, 2026
Delaware Supreme Court Reverses Moelis Governance Ruling
The Delaware Supreme Court on Tuesday reversed a Chancery Court ruling that had invalidated key provisions of Moelis & Co.'s stockholder agreement, holding that the challenged governance provisions were not void but merely voidable, and that a stockholder challenge brought nearly nine years later was time-barred.
-
January 20, 2026
Luminys Back In Clear With FCC After Dahua USA Is Dissolved
Luminys can once again market its telecom equipment in the U.S. now that the onetime Chinese-controlled firm Dahua USA has been dissolved, the Federal Communications Commission said Tuesday.
-
January 20, 2026
Preservation Group Seeks Expert Visit Of WH Ballroom Site
The National Trust for Historic Preservation on Tuesday asked a D.C. federal judge to allow one of its architectural experts to inspect work underway at the former East Wing of the White House, a section demolished by the Trump administration in October to make way for a new ballroom.
-
January 20, 2026
Ex-Mars Exec Deserves 'Substantial' Fraud Sentence, Feds Say
A former Mars Inc. risk executive who admitted to pulling off a $28.4 million fraud scheme should spend a "substantial" amount of time in prison, prosecutors told a Connecticut federal judge, noting that the parties agreed to a guidelines range of around seven to 11 years.
-
January 20, 2026
North Carolina AG Wins Bid To End MV Realty's 40-Year Deals
Florida real estate company MV Realty defied state consumer protection statutes in North Carolina by tricking homeowners into signing decades-long listing agreements in exchange for small cash advances, a state Business Court judge said in handing the attorney general a major pretrial victory.
-
January 20, 2026
Immigration Courts 'Ignoring' Bond Hearing Order, Judge Says
A Massachusetts federal judge said Tuesday that immigration court judges appear to be "effectively ignoring" rulings by her and other district judges to grant bond hearings for detainees, but acknowledged there's little she can do about it.
-
January 20, 2026
Coinbase And Kalshi Contracts 'Siphoning' Money, Tribes Say
Battles between crypto titan Coinbase, derivative exchange KalshiEX LLC and Connecticut officials over the legality of sports-related event contracts directly impact "tribal sovereignty over gaming that occurs on Indian lands," a coalition of American Indian tribes and tribal associations told a federal judge in proposed amicus briefs that side with the state government.
-
January 20, 2026
CorMedix Investors Seek First OK Of Governance Reform Deal
Investors in CorMedix Inc. have told a New Jersey federal judge that company directors have agreed to implement several corporate governance reforms to resolve a consolidated shareholder derivative lawsuit accusing the executives of making misleading statements about delays in the regulatory approval of the company's lead drug candidate.
-
January 20, 2026
Senior DOJ Fraud Atty Joins Akin Amid Surge In FCA Cases
Akin Gump Strauss Hauer & Feld LLP has expanded its bench of former public servants, announcing Tuesday the hire of a senior trial counsel from the U.S. Department of Justice's Civil Fraud Section, shortly after the agency revealed last week a record $6.8 billion in False Claims Act judgments and settlements in the most recent fiscal year.
-
January 20, 2026
Ogletree Adds Federal Agency Vets As Practice Co-Chairs
Ogletree Deakins Nash Smoak & Stewart PC announced Tuesday that it has tapped a prominent U.S. Securities and Exchange Commission alum from Arnold & Porter Kaye Scholer LLP to co-chair its whistleblower and compliance practice group and a former U.S. Department of Justice litigator from Booz Allen Hamilton to co-chair its government contracting and reporting practice group.
-
January 20, 2026
Texas, Fla. AGs Pen Opinions On 'Unconstitutional' DEI Efforts
The attorneys general of Florida and Texas both issued opinions calling diversity, equity and inclusion requirements and laws unconstitutional.
-
January 20, 2026
CFTC Chair Calls Up Ex-BigLaw Atty For Adviser Role
U.S. Commodity Futures Trading Commission Chair Michael Selig on Tuesday appointed a former Simpson Thacher & Bartlett LLP crypto attorney and a former Treasury Department employee to advise him as he promised to update the agency's rulebook to "unleash innovation."
-
January 20, 2026
Compliance Expert Moves Practice To Jenner & Block
An attorney specializing in managing federal compliance regulations with expertise in the higher education, healthcare and life sciences industries has moved his practice to Jenner & Block LLP's Washington, D.C., office.
-
January 20, 2026
NJ Sues Nursing Home Owners Over Missing Medicaid Funds
The New Jersey Office of the State Comptroller has demanded the owners of two Garden State nursing homes repay millions in Medicaid funds the office recently found they diverted to themselves while neglecting their facilities' residents, according to a complaint filed Monday.
-
January 20, 2026
Catching Up With Delaware's Chancery Court
The Delaware Chancery Court wrapped up last week with a mix of deal litigation, governance fights and disclosure battles, including a proposed settlement over a contested medical device sale, a merits dismissal tied to a $2 billion biotech exit and dueling lawsuits over Paramount Skydance's pursuit of Warner Bros. Discovery.
-
January 20, 2026
Mass. Judge Slams Brakes On Kalshi Sports Offerings
Prediction market operator Kalshi will soon be barred from offering sports event contracts in Massachusetts after a state judge ruled Tuesday that the contracts are likely functioning as unlicensed sports wagering.
-
January 20, 2026
DC Judge Won't Block Limits On Detention Visits, For Now
A Washington federal judge has determined that Democratic lawmakers used the wrong procedure to challenge a new Trump administration policy requiring members of Congress to provide notice before making oversight visits to immigrant detention facilities, but also said they could try again.
-
January 20, 2026
Barnes & Thornburg Adds Steptoe White Collar Pro In DC
Barnes & Thornburg LLP has expanded its white collar, compliance and investigations practice in the nation's capital with a veteran litigator from Steptoe LLP, the firm said Tuesday.
-
January 20, 2026
Alaska Says Imminent Harm Missing In Arctic Drilling Suit
The state of Alaska has told a federal judge that environmental groups sued too early over a move last year by President Donald Trump to revive the prospect of Arctic oil and gas leasing in offshore areas that prior administrations deemed off-limits.
-
January 20, 2026
Chamber Tells 5th Circ. EPA Asbestos Ban Goes Too Far
The U.S. Chamber of Commerce is urging the Fifth Circuit to vacate a 2024 rule by the U.S. Environmental Protection Agency banning the use of chrysotile asbestos, saying the agency overstepped its authority without consulting other regulators as it was required to.
-
January 20, 2026
Justices Ax 6th Circ. Abortion Order Amid Loper Bright Outcry
The U.S. Supreme Court on Tuesday erased a Sixth Circuit decision allowing abortion-related conditions on family planning grants, a victory for Tennessee officials who accused the circuit of flouting the high court's landmark rejection of judicial deference to regulators.
Expert Analysis
-
Key Strategies For Supplement Cos. Facing Lead Risks
In the wake of a recent Consumer Reports article detailing dangerously high levels of lead in many popular protein powders, supplement companies face increased litigation, rising enforcement risks and reputational harm — underscoring the need to monitor supply chains, test ingredients and understand labeling standards, say attorneys at Husch Blackwell.
-
How AI Tech Suppliers Can Address IP Lawyers' Concerns
While artificial intelligence tools can help intellectual property lawyers be more productive and effective, AI tech providers must address issues of privilege, data privacy and confidentiality to make their technology viable and useful for IP law, say Tom Colson at Colson Law and Kevin Bronson at Simpson & Simpson.
-
From Bank Loans To Private Credit: Tips For Making The Shift
The relationship between private credit and syndicated bank deals will evolve as the private market continues to grow, introducing new challenges for borrowers comparing financing options, particularly pertaining to loan documentation and working capital, say attorneys at Haynes Boone.
-
3 Takeaways From FDA Cell And Gene Therapy Draft Guidance
The U.S. Food and Drug Administration recently published draft guidance documents that sketch the clearest picture yet of the evolving regulatory framework for cell and gene therapies, reflecting an agency that is increasingly comfortable with flexible, science-driven approaches that extend beyond clinical trial models, say attorneys at MoFo.
-
Wells Process Reforms Serve SEC Chair's Transparency Goals
Enforcement policy changes U.S. Securities and Exchange Commission Chairman Paul Atkins recently set forth will help fulfill his stated goal of making Division of Enforcement investigations more fair and transparent by changing the Wells process to provide recipients earlier consultations with SEC staff, greater evidence access and more time to file responses, say attorneys at Dechert.
-
The Ins And Outs Of Decentralized Digital Asset Exchanges
As decentralized digital asset exchanges lack intermediaries, and so remain susceptible to fraud and market manipulation, an understanding of their design is crucial to help market participants avoid fraudulent practices such as liquidity rug pulls, says Swati Kanoria at Charles River.
-
Contradictory Rulings Show Complexity Of Swaps Regulation
Recent divergent rulings, including two by the same Nevada judge, on whether the Commodity Exchange Act preempts state gambling laws when applied to event contracts traded on U.S. Commodity Futures Trading Commission-regulated markets illustrate the uncertainty regarding the legality of prediction markets, say attorneys at Akin.
-
How New Law Transforms Large-Load Power Projects In Texas
S.B. 6 — the new Texas law that revises state regulations for large electrical loads and related behind-the-meter projects — introduces higher up-front costs for developers and more flexible operating models for large-load customers, but should provide the certainty needed for greater investment in generation, say attorneys at Sidley.
-
How Cos. Should Prepare For Prop 65 Listing Of Bisphenols
California regulators are moving toward classifying all p,p'-bisphenol chemicals as causing reproductive toxicity under Proposition 65, which could require warning notices for a vast range of consumer and industrial products, and open the floodgates to private litigation — so companies should proactively review their suppy chains, says Gregory Berlin at Alston & Bird.
-
Rule Amendments Pave Path For A Privilege Claim 'Offensive'
Litigators should consider leveraging forthcoming amendments to the Federal Rules of Civil Procedure, which will require early negotiations of privilege-related discovery claims, by taking an offensive posture toward privilege logs at the outset of discovery, says David Ben-Meir at Ben-Meir Law.
-
Series
My Miniature Livestock Farm Makes Me A Better Lawyer
Raising miniature livestock on my farm, where I am fully present with the animals, is an almost meditative time that allows me to return to work invigorated, ready to juggle numerous responsibilities and motivated to tackle hard issues in new ways, says Ted Kobus at BakerHostetler.
-
When Mortgage Data Can't Prove Discriminatory Lending
As plaintiffs continue to use Home Mortgage Disclosure Act data as grounds for class actions, attorneys must consider the limits of a statistics-only approach and the need for manual loan file review to confirm indications of potential discriminatory lending, say Abe Chernin, Shane Oka and Kevin Oswald at Cornerstone Research.
-
NLRB Memo Shifts Tone On Defenses Against Union 'Salting'
The current Starbucks strike demonstrates the potential effects of salting, in which applicants seek employment in order to organize a union, and recent guidance from the National Labor Relations Board suggests that previously rejected employer defenses may now gain traction, says Daniel Johns at Cozen O'Connor.
-
Evaluating Nasdaq Tokenization Rule's Potential Impact
Nasdaq's recently proposed rule would enable settlement of tokenized equity securities and exchange-traded products using blockchain technology, which could lead to dramatic improvements in market efficiency, settlement speed and market access, but prudent skepticism about timelines and implementation capabilities is warranted, says James Brady at Katten.
-
FDA Biosimilar Guidance Should Ease Biologics Development
New draft guidance from the U.S. Food and Drug Administration, indicating that the agency may no longer routinely require comparative efficacy studies when other evidence provides sufficient assurance of biosimilarity, underscores the FDA's trust in analytical technology as a driver of biologics access, say attorneys at Hogan Lovells.